Alkem Laboratories Limited

Web: alkemlabs.com NSE: ALKEM BSE: 539523 SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

5188 6(0%)

Near 52W Low of 5075

Volume

96k as on 03, Sep

Open

5,280

High

5,290

Low

5,258

5,193

VWAP

5,194

52 Week High

5,934

52 Week Low

5,075

Viand Research Rating

Quality Score

25/100

Growth Score

17/100

Valuation Score

50/100

Momentum Score

0/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

62,024

No. of Shares

P/E

30.93

P/B

5.54

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

17.93

ROCE

Profit Growth

Listing Date

23-Dec-15

Promoter Holding

49.7%

FII Holding

10.42%

DII Holding

22.64%

Price Chart

Price Performance

1 Week2%

1 Month9%

3 Months2%

6 Months7%

1 Year2%

YTD5%

Moving Average

5 Day SMA5,278

10 Day SMA5,313

20 Day SMA5,390

30 Day SMA5,485

50 Day SMA5,528

61 Day SMA5,497

80 Day SMA5,474

200 Day SMA5,527

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	5,372	5,238	5,331	5,363
Resistance 2	5,331	5,229	5,292	5,326
Resistance 1	5,270	5,219	5,268	5,261
Pivot Point	5,229	5,210	5,229	5,224
Support 1	5,168	5,201	5,190	5,159
Support 2	5,127	5,191	5,166	5,122
Support 3	5,066	5,182	5,127	5,057

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,56,655	1899	0%	2%	9%	21%	37	57.7	0.07	11509
2	DIVISLAB	2,43,196	9161	2%	8%	44%	51%	69	57.7	0	2568
3	TORNTPHARM	1,84,303	4846	2%	3%	12%	36%	72	57.7	1.79	2138
4	APOLLOHOSP	1,24,834	8650	1%	1%	12%	10%	58	57.7	0.9	2003
5	ZYDUSLIFE	1,12,897	1132	4%	2%	26%	13%	20	57.7	0.46	5124
6	CIPLA	1,11,346	1385	2%	5%	3%	12%	22	57.7	0.02	3862
7	LAURUSLABS	99,634	1844	3%	3%	75%	114%	0	57.7	0.48	890
8	DRREDDY	96,962	1151	2%	2%	11%	8%	20	57.7	0.2	4158
9	MAXHEALTH	96,646	985	1%	10%	8%	14%	0	57.7	0.32	1442
10	LUPIN	96,620	2113	1%	11%	8%	10%	23	57.7	0.29	5355
Load More

Shareholding Pattern (%)

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(-1.51) 49.70%	(0.01) 51.20%	(0.01) 51.20%	(-1.81) 51.20%	(-2.11) 53.04%	(-0.51) 55.13%	(0.01) 55.66%	(-0.71) 55.66%	(-0.41) 56.38%	(0.01) 56.74%	(0.01) 56.74%	(-0.41) 56.74%	(0.01) 57.16%	(0.01) 57.16%	(0.01) 57.16%	(0.01) 57.16%	(0.01) 57.14%	(0.01) 57.13%	(-1.71) 57.13%	(0.01) 58.84%
FIIs	(0.31) 10.42%	(0.21) 10.15%	(0.51) 9.97%	(0.41) 9.47%	(-0.31) 9.11%	(-0.71) 9.40%	(1.11) 10.14%	(0.31) 9.02%	(-0.41) 8.69%	(0.61) 9.11%	(2.51) 8.49%	(0.41) 6.03%	(1.21) 5.63%	(0.01) 4.44%	(0.01) 4.41%	(-1.21) 4.46%	(0.31) 5.67%	(0.01) 5.41%	(0.11) 5.40%	(0.01) 5.33%
DIIs	(1.31) 22.64%	(-0.11) 21.39%	(-0.41) 21.54%	(0.11) 21.93%	(2.41) 21.80%	(1.41) 19.42%	(-1.21) 18.01%	(0.71) 19.21%	(2.91) 18.56%	(-0.31) 15.63%	(-1.71) 15.91%	(1.31) 17.63%	(-0.41) 16.34%	(0.31) 16.69%	(0.71) 16.44%	(1.61) 15.73%	(0.01) 14.10%	(0.21) 14.14%	(-0.11) 13.94%	(0.01) 13.99%
Public	17.25%	17.25%	17.30%	17.39%	16.05%	16.05%	16.19%	16.12%	16.37%	18.51%	18.86%	19.58%	20.85%	21.69%	21.99%	22.65%	23.09%	23.32%	23.53%	21.84%
No. of Shareholders	62,822	62,835	64,536	67,196	79,740	84,326	84,038	74,744	69,627	65,830	65,184	69,442	66,790	73,440	76,516	79,721	84,104	81,869	86,881	87,392

Quarterly Results

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
Sales	3740	3603	3737	4001	3371	3144	3374	3415	3032	2936	3324	3440	2968	2903	3041	3079	2576	2484	2619	2800	2731
Sales Growth % (YoY)	11%	14.6%	10.7%	17.2%	11.2%	7.1%	1.5%	-0.7%	2.2%	1.1%	9.3%	11.7%	15.2%	16.9%	16.1%	10%	-5.7%	13.3%	13%	18.5%	37.1%
Sales Growth % (QoQ)	3.8%	-3.6%	-6.6%	18.7%	7.2%	-6.8%	-1.2%	12.6%	3.3%	-11.7%	-3.4%	15.9%	2.2%	-4.5%	-1.2%	19.5%	3.7%	-5.2%	-6.5%	2.5%	-
Expenses	2974	3086	2909	3080	2632	2752	2615	2662	2423	2534	2616	2693	2579	2549	2442	2625	2373	2147	2121	2176	2138
Operating Profit	766	517	828	921	739	391	759	753	609	402	708	747	389	353	599	454	203	337	498	624	593
OPM %	20	14	22	23	22	12	23	22	20	14	21	22	13	12	20	15	8	14	19	22	22
Other Income	153	65	90	104	149	146	93	134	120	76	42	6	66	-34	45	51	51	6	54	42	47
Interest	47	54	42	35	30	28	36	28	29	27	25	30	30	29	27	25	26	17	11	12	13
Depreciation	100	106	95	94	88	112	85	79	80	83	70	74	72	78	78	77	76	83	77	73	71
Profit before tax	772	423	781	896	771	396	731	780	619	367	655	648	353	212	539	402	152	243	464	582	556
Tax %	32	40	16	13	13	18	12	10	11	17	8	5	18	68	15	14	13	55	-15	4	14
Net Profit	521	251	653	779	668	322	641	702	550	304	604	615	288	68	460	348	131	108	533	559	480
Net Profit Growth % (QoQ)	107.6%	-61.6%	-16.2%	16.6%	107.5%	-49.8%	-8.7%	27.6%	80.9%	-49.7%	-1.8%	113.5%	323.5%	-85.2%	32.2%	165.6%	21.3%	-79.7%	-4.7%	16.5%	-
Net Profit Growth % (YoY)	-22%	-22%	1.9%	11%	21.5%	5.9%	6.1%	14.1%	91%	347.1%	31.3%	76.7%	119.8%	-37%	-13.7%	-37.7%	-72.7%	-	-	-	-
TTM Net Profit	2204	2351	2422	2410	2333	2215	2197	2160	2073	1811	1575	1431	1164	1007	1047	1120	1331	1680	1572	1039	0
EPS in Rs	43.49	19.78	53.19	63.99	55.56	25.58	52.34	57.6	45.6	24.55	49.76	51.9	23.98	5.94	38.03	27.67	10.68	9	43.96	45.52	39.15

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Sales	14712	12965	12668	11599	10634	8865	8344	7357	6401	5688	4905	3674	3113	2485
Sales Growth %	13.5%	2.3%	9.2%	9.1%	20%	6.2%	13.4%	14.9%	12.6%	16%	33.5%	18%	25.3%	23.6%
Expenses	11706	10452	10419	9977	8580	6920	6868	6237	5392	4687	4038	3248	2700	2123
Operating Profit	3007	2512	2249	1622	2054	1945	1476	1120	1009	1001	866	427	413	362
OPM %	20	19	18	14	19	22	18	15	16	18	18	12	13	15
Other Income	407	494	186	101	146	230	102	82	115	110	227	176	162	167
Interest	161	122	112	107	52	59	65	55	55	45	71	81	93	88
Depreciation	382	357	299	310	304	275	253	193	143	101	93	71	52	40
Profit before tax	2871	2527	2023	1305	1844	1842	1260	955	926	965	928	451	430	402
Tax %	18	12	10	23	9	12	9	19	31	6	19	13	-1	4
Net Profit	2351	2215	1811	1007	1680	1618	1149	774	638	905	752	392	435	384
Net Profit Growth %	6.1%	22.3%	79.8%	-40.1%	3.8%	40.8%	48.4%	21.3%	-29.5%	20.3%	91.8%	-9.9%	13.3%	-
EPS in Rs	192.51	181.11	150.19	82.31	137.63	132.57	94.26	63.61	52.77	74.61	62.02	32.75	364.1	321.01
Dividend Payout %	28	25	27	61	25	23	27	25	25	20	20	12	5	6

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Cash from Operating Activity	1963	1913	1948	1682	1111	1265	585	780	266	471	726	325	290	78
Cash from Investing Activity	-1682	-1288	-1011	120	-1433	-995	-737	-318	-351	-294	205	-235	353	-403
Cash from Financing Activity	-503	-811	-1145	-1761	380	-272	79	-379	85	-138	-927	-52	-600	356
Net Cash Flow	-222	-186	-207	42	58	-2	-73	82	0	40	3	39	44	31

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Equity Capital	24	24	24	24	24	24	24	24	24	24	24	24	24	24	12	12
Reserves	13796	13322	11961	11469	10288	9021	8614	7353	6137	5415	4840	4444	3668	2975	2567	2160
Borrowings	2047	2356	1381	1478	1418	1397	2668	1707	1616	944	998	659	658	1306	1128	1552
Other Liabilities	4991	4586	4325	4146	3844	3315	2763	2435	2169	1824	1803	1440	1184	986	604	547
Total Liabilities	20858	20287	17691	17117	15575	13757	14069	11519	9946	8208	7664	6568	5534	5291	4311	4271
Fixed Assets	3871	3319	2852	2807	2873	2683	2902	2793	2908	2530	2284	1797	1450	1374	1170	1072
CWIP	282	653	548	292	159	323	339	393	363	493	381	299	172	111	0	0
Investments	1869	2533	1846	1160	484	622	371	333	261	324	444	553	509	481	588	478
Other Assets	14836	13783	12445	12858	12060	10129	10457	8000	6413	4861	4555	3918	3403	3325	2553	2721
Total Assets	20858	20287	17691	17117	15575	13757	14069	11519	9946	8208	7664	6568	5534	5291	4311	4271

Delivery

Delivery Data: ALKEM

#	Date	5130 15% 5882	Value (Cr)	Q/T 9	Del 52	Del 114
1	4-Sep	5190	33	6	55	18
2	3-Sep	5193	50	8	66	33
3	2-Sep	5210	114	11	69	79
4	1-Sep	5300	47	9	59	28
5	31-Aug	5330	64	11	72	46
6	28-Aug	5355	124	14	67	83
7	27-Aug	5320	89	9	74	65
8	26-Aug	5304	24	6	48	11
9	25-Aug	5368	26	5	55	14
10	24-Aug	5350	25	5	56	14
11	21-Aug	5400	41	6	55	23
12	20-Aug	5400	46	10	76	35
13	19-Aug	5382	116	6	66	76
14	18-Aug	5475	70	6	28	20
15	17-Aug	5374	83	6	36	30
16	14-Aug	5368	339	9	32	107
17	13-Aug	5450	18	4	46	8
18	12-Aug	5480	60	6	59	36
19	11-Aug	5528	64	5	48	31
20	10-Aug	5598	46	5	53	24
21	7-Aug	5620	43	7	32	14
22	6-Aug	5598	62	5	62	38
23	5-Aug	5696	50	5	52	26
24	4-Aug	5608	21	4	54	12
25	3-Aug	5707	70	6	61	43
26	31-Jul	5752	67	7	59	40
27	30-Jul	5816	175	8	34	59
28	29-Jul	5672	33	7	56	18
29	28-Jul	5652	33	5	46	15
30	27-Jul	5613	63	5	57	36
31	24-Jul	5634	31	4	56	17
32	23-Jul	5602	28	4	43	12
33	22-Jul	5585	61	5	37	23
34	21-Jul	5682	16	5	53	8
35	20-Jul	5654	62	6	52	32
36	17-Jul	5563	39	6	55	22
37	16-Jul	5709	39	6	51	20
38	15-Jul	5659	121	13	75	91
39	14-Jul	5602	292	10	67	195
40	13-Jul	5567	122	10	62	76
41	10-Jul	5670	59	5	60	36
42	9-Jul	5648	22	5	48	11
43	8-Jul	5606	57	6	48	27
44	7-Jul	5668	114	6	61	70
45	6-Jul	5598	55	8	56	31
46	3-Jul	5562	317	14	69	220
47	2-Jul	5500	90	6	65	59
48	1-Jul	5568	71	7	60	43
49	30-Jun	5570	188	8	52	99
50	29-Jun	5416	105	7	54	57

Daily Market Cap

Date	Total Market Cap	Change	Chg %
04-Sep	62,024c	275c	0.45
03-Sep	61,749c	1,847c	2.90
01-Sep	63,597c	257c	0.40
31-Aug	63,854c	155c	0.24
26-Aug	64,009c	502c	0.79
25-Aug	63,507c	460c	0.72
24-Aug	63,967c	42c	0.07
21-Aug	63,925c	430c	0.67
19-Aug	64,356c	1,106c	1.69
18-Aug	65,462c	1,208c	1.88
17-Aug	64,254c	72c	0.11
14-Aug	64,183c	909c	1.40
13-Aug	65,091c	430c	0.66
12-Aug	65,522c	1,339c	2.00
10-Aug	66,861c	227c	0.34
06-Aug	67,088c	120c	0.18
05-Aug	66,968c	84c	0.12
04-Aug	67,052c	945c	1.39
03-Aug	67,997c	574c	0.84
31-Jul	68,571c	1,226c	1.76
30-Jul	69,796c	1,853c	2.73
29-Jul	67,943c	299c	0.44
28-Jul	67,644c	508c	0.76
27-Jul	67,136c	0	0

Stock Checklist

Price is above from 52 week high low average: 13%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: NO

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: YES

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 329 fund scheme(s) across 31 fund house(s) as of Aug26 · Total value ₹21,881 Cr · 124 increasing / 87 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
HDFC Mutual Fund	32	1.00%	-0.01%	6518.8
ICICI Prudential Mutual Fund	28	0.79%	-0.14%	3315.4
DSP Mutual Fund	34	1.51%	+0.82%	2986
Nippon India Mutual Fund	20	0.65%	+0.03%	2054.1
SBI Mutual Fund	14	0.57%	-0.05%	1917.5
ICICI Prudential Asset Management Company Limited	3	0.93%	+0.01%	1719.1
Axis Mutual Fund	12	1.37%	+0.53%	1124.5
Sundaram Mutual Fund	20	1.06%	+0.16%	866
NJ Mutual Fund	6	2.97%	-	363.6
Tata Mutual Fund	16	0.54%	+0.02%	349.8
WhiteOak Capital Mutual Fund	8	0.92%	-0.01%	229.2
Mirae Asset Mutual Fund	8	1.71%	+0.32%	202.9
Mahindra Manulife Mutual Fund	6	0.74%	-	161.4
Edelweiss Mutual Fund	14	0.22%	+0.43%	122.2
UTI Mutual Fund	12	0.52%	-0.10%	94.1
Motilal Oswal Mutual Fund	12	0.61%	+0.19%	90.1
Baroda BNP Paribas Mutual Fund	8	0.75%	+0.54%	63.9
Aditya Birla Sun Life Mutual Fund	12	0.08%	+0.64%	61
Samco Mutual Fund	4	3.77%	-	28.8
360 ONE Mutual Fund	2	1.51%	+1.51%	26.4
ITI Mutual Fund	2	2.92%	+0.17%	15.4
LIC Mutual Fund	4	1.51%	-0.03%	11.8
Navi Mutual Fund	8	0.76%	-0.01%	7.6
Zerodha Mutual Fund	4	0.41%	-	7.5
Jio BlackRock Mutual Fund	2	0.61%	-0.01%	2.7
Groww Mutual Fund	8	0.26%	+0.05%	2.7
Bandhan Mutual Fund	8	0.02%	-0.11%	2.5
Angel One Mutual Fund	2	0.16%	-0.01%	0.2
HSBC Mutual Fund	2	0.00%	-	0.1
Invesco Mutual Fund	2	-0.11%	+0.09%	-51.7
Kotak Mahindra Mutual Fund	16	-0.19%	-0.23%	-412

Alkem Laboratories Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements